TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | -1 | -2 | 8 | 23 | 42 | 246 | 53 |
| P | %wins | 0 | 0 | 100 | 100 | 100 | 100 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/21/26 17:07 | 9/21/26 | CYBN | Cybin Inc. | A6 | Health | Drug | Pharmaceutical Preparations | Halstead Michael | O | CEO | P | 1,347 | 13.47 | 0 | 100 | 146 | 169 | D | |||||||||||||||
11/6/14 16:53 | 11/5/14 | ITCI | Intra-Cellular Therapies, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Halstead Michael | NY | O | SVP,GC | P.m | 308 | 15.38 | 1 | 20 | New | 20 | D | -7 | 6 | 15 | -5 | 2 | -2 | -1 | -2 | 8 | 23 | 42 | 246 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |